Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group-Reference-Cited by-同舟云学术

Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Published:2021-11-08 Issue:12 Volume:35 Page:3585-3588
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Spanjaart Anne Mea,Ljungman Per^ORCID,de La Camara Rafael^ORCID,Tridello Gloria,Ortiz-Maldonado Valentín,Urbano-Ispizua Alvaro,Barba Pere^ORCID,Kwon Mi^ORCID,Caballero Dolores,Sesques Pierre,Bachy Emmanuel,Di Blasi Roberta,Thieblemont Catherine,Calkoen Friso^ORCID,Mutsaers Pim^ORCID,Maertens Johan^ORCID,Giannoni Livia,Nicholson Emma,Collin Matthew^ORCID,Vaz Carlos Pinho,Metafuni Elisabetta,Martinez-Lopez Joaquin,Dignan Fiona L.,Ribera Josep-Maria,Nagler Arnon,Folber Frantisek,Sanderson Robin,Bloor Adrian^ORCID,Ciceri Fabio,Knelange Nina,Ayuk Francis,Kroger Nicolaus,Kersten Marie José,Mielke Stephan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01466-0.pdf

Reference15 articles.

1. Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136:2881–92.

2. Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021. https://doi.org/10.1038/s41375-021-01302-5.

3. Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8:185–93.

4. Aydillo T, Gonzalez-Reiche AS, Aslam S, van de Guchte A, Khan Z, Obla A, et al. Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer. N Engl J Med. 2020;383:2586–8.

5. Shah GL, DeWolf S, Lee YJ, Tamari R, Dahi PB, Lavery JA, et al. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation. J Clin Investig. 2020;130:6656–67.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies;Blood;2024-09-12

2. COVID-19 in the immunocompromised host;COVID-19: An Update;2024-09-01

3. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

4. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

5. COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 Therapeutics;Transplantation and Cellular Therapy;2024-08